1. BIOS-02. CLINICAL OUTCOMES OF OVER 600 PATIENTS WITH GLIOBLASTOMA TREATED AT A CANADIAN TERTIARY CENTER IN THE PAST 15 YEARS: A COMPARATIVE ANALYSIS WITH THE PIVOTAL STUPP TRIAL. (14th November 2022) Authors: Rousseau, Julien; Desforges, Sara-Maude; Jabbour, Gilbert; Lemieux, Bernard; Lapointe, Sarah; Bélanger, Karl; Moumdjian, Robert; Cayrol, Romain; Florescu, Marie; Masucci, Giuseppina Laura; Berthelet, France; Lemieux-Blanchard, Émilie; Bahary, Jean-Paul Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Central neurogenic hyperventilation in conscious patients due to CNS neoplasm: a case report and review of the literature on treatment. Issue 5 (10th April 2020) Authors: Neves Briard, Joel; Beaulieu, Marie-Claude; Lemoine, Émile; Beaulieu, Camille; Dubé, Bruno-Pierre; Lapointe, Sarah Journal: Neuro-oncology practice Issue: Volume 7:Issue 5(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Issue 1 (22nd October 2020) Authors: Schulte, Jessica D; Buerki, Robin A; Lapointe, Sarah; Molinaro, Annette M; Zhang, Yalan; Villanueva-Meyer, Javier E; Perry, Arie; Phillips, Joanna J; Tihan, Tarik; Bollen, Andrew W; Pekmezci, Melike; Butowski, Nicholas; Oberheim Bush, Nancy Ann; Taylor, Jennie W; Chang, Susan M; Theodosopoulos, P... Journal: Neuro-oncology advances Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PATH-10. A CASE OF ADULT THALAMIC DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED WITH AN IMPRESSIVE RESPONSE TO RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE. (14th November 2022) Authors: Rousseau, Julien; Labidi, Moujahed; Bahary, Jean-Paul; Bélanger, Karl; Berthelet, France; Lapointe, Sarah Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PATH-30. CLINICAL AND GENETIC CHARACTERISTICS OF HISTONE H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IN ADULTS. (9th November 2020) Authors: Schulte, Jessica; Buerki, Robin; Lapointe, Sarah; Molinaro, Annette; Zhang, Yalan; Villanueva-Meyer, Javier; Perry, Arie; Phillips, Joanna; Tihan, Tarik; Bollen, Andrew; Pekmezci, Melike; Butowski, Nicholas; Bush, Nancy Ann Oberheim; Taylor, Jennie; Chang, Susan; Theodosopoulos, Philip; Aghi, Man... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Primary brain tumours in adults. Issue 10145 (4th August 2018) Authors: Lapointe, Sarah; Perry, Arie; Butowski, Nicholas A Journal: Lancet Issue: Volume 392:Issue 10145(2018) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. QOL-25. IMPACTS OF IMPLEMENTING A PROSPECTIVE TREATMENT AND SURVEILLANCE PROTOCOL FOR THE MANAGEMENT OF NF2-ASSOCIATED VESTIBULAR SCHWANNOMAS ON TUMOR GROWTH, HEARING OUTCOMES, AND QUALITY OF LIFE. (14th November 2022) Authors: Rousseau, Julien; Dahoud, Andrea; Labidi, Moujahed; El Haffaf, Zaki; Florescu, Marie; Saliba, Issam; Gosselin, Marie-Hélène; Lapointe, Sarah Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗